Feasibility of opportunistic bone health assessment using low-dose CT trabecular attenuation and 18F-NaF uptake from PET/CT in prostate cancer - Top-Institutions - MDSpire

Evaluation of the Viability of Opportunistic Bone Health Evaluation Utilizing Low-Dose CT Trabecular Attenuation and 18F-NaF PET/CT Uptake in Prostate Cancer Patients

  • By

  • Cailing Liu

  • Fenghua Liang

  • Zuguo Li

  • Zhenzhen Wang

  • Wei Fu

  • Xingyu Mu

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    our institution
    our institution

    Unknown, Unknown

    Key Differentiators

    • Oncology

  • #2

    our medical center
    our medical center

    Unknown, Unknown

    Key Differentiators

    • Oncology

  • #3

    St Vincent's Hospital, Sydney
    St Vincent's Hospital, Sydney

    Sydney, NSW

    Key Differentiators

    • Oncology

  • #4

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, VIC

    Key Differentiators

    • Oncology

  • #5

    Martini-Klinik Prostate Cancer Center, Germany
    Martini-Klinik Prostate Cancer Center, Germany

    Hamburg, Germany

    Key Differentiators

    • Oncology

Original Source(s)

Feasibility of opportunistic bone health assessment using low-dose CT trabecular attenuation and 18F-NaF uptake from PET/CT in prostate cancer

  • by Cailing Liu, Fenghua Liang, Zuguo Li, Zhenzhen Wang, Wei Fu, Xingyu Mu

  • July 20, 2026

Related Content

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

Case Report: Evolution of intratumoral spatial heterogeneity assessed by [68Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma